Elevation Oncology Inc (ELEV)
3.84
+0.02
(+0.52%)
USD |
NASDAQ |
May 03, 14:24
Elevation Oncology Price to Book Value: 3.409 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 3.391 |
| May 01, 2024 | 3.551 |
| April 30, 2024 | 3.151 |
| April 29, 2024 | 3.417 |
| April 26, 2024 | 3.213 |
| April 25, 2024 | 3.236 |
| April 24, 2024 | 3.444 |
| April 23, 2024 | 3.835 |
| April 22, 2024 | 3.595 |
| April 19, 2024 | 3.373 |
| April 18, 2024 | 3.560 |
| April 17, 2024 | 3.675 |
| April 16, 2024 | 3.897 |
| April 15, 2024 | 3.932 |
| April 12, 2024 | 4.199 |
| April 11, 2024 | 4.385 |
| April 10, 2024 | 4.083 |
| April 09, 2024 | 4.181 |
| April 08, 2024 | 4.119 |
| April 05, 2024 | 4.358 |
| April 04, 2024 | 4.492 |
| April 03, 2024 | 4.589 |
| April 02, 2024 | 4.554 |
| April 01, 2024 | 4.429 |
| March 28, 2024 | 4.554 |
| Date | Value |
|---|---|
| March 27, 2024 | 4.447 |
| March 26, 2024 | 4.438 |
| March 25, 2024 | 4.065 |
| March 22, 2024 | 3.994 |
| March 21, 2024 | 4.003 |
| March 20, 2024 | 3.852 |
| March 19, 2024 | 3.906 |
| March 18, 2024 | 3.870 |
| March 15, 2024 | 3.897 |
| March 14, 2024 | 3.515 |
| March 13, 2024 | 3.702 |
| March 12, 2024 | 3.622 |
| March 11, 2024 | 3.897 |
| March 08, 2024 | 4.057 |
| March 07, 2024 | 3.994 |
| March 06, 2024 | 4.145 |
| March 05, 2024 | 4.145 |
| March 04, 2024 | 4.270 |
| March 01, 2024 | 4.447 |
| February 29, 2024 | 3.413 |
| February 28, 2024 | 2.980 |
| February 27, 2024 | 2.872 |
| February 26, 2024 | 2.245 |
| February 23, 2024 | 1.982 |
| February 22, 2024 | 2.090 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2293
Minimum
Sep 22 2022
4.589
Maximum
Apr 03 2024
1.073
Average
0.6081
Median
Price to Book Value Benchmarks
| Merrimack Pharmaceuticals Inc | 11.64 |
| Mersana Therapeutics Inc | 11.46 |
| Equillium Inc | 2.616 |
| Monopar Therapeutics Inc | 2.187 |
| Larimar Therapeutics Inc | 5.871 |
Price to Book Value Related Metrics
| Price | 3.84 |
| Earnings Yield | -38.28% |
| Market Cap | 186.82M |